Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
2.110
+0.060 (2.93%)
At close: Nov 21, 2024, 4:00 PM
2.120
+0.010 (0.47%)
After-hours: Nov 21, 2024, 4:31 PM EST
Allogene Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 442 | 540 | 907 | 2,126 | 3,541 | 3,167 | |
| Market Cap Growth | 10.19% | -40.45% | -57.34% | -39.95% | 11.80% | -3.19% | |
| Enterprise Value | 231 | 171 | 457 | 1,697 | 2,753 | 2,704 | |
| Last Close Price | 2.05 | 3.21 | 6.29 | 14.92 | 25.24 | 25.98 | |
| PS Ratio | 13616.56 | 5685.98 | 5814.63 | 18.64 | - | - | |
| PB Ratio | 0.93 | 1.05 | 1.36 | 2.32 | 3.28 | 5.03 | |
| P/TBV Ratio | 1.26 | 1.05 | 1.36 | 2.32 | 3.28 | 5.04 | |
| EV/Sales Ratio | 5367.16 | 1803.61 | 2931.99 | 14.87 | - | - | |
| Debt / Equity Ratio | 0.20 | 0.19 | 0.15 | 0.08 | 0.05 | 0.08 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.10 | - | - | |
| Quick Ratio | 9.04 | 12.15 | 9.69 | 9.62 | 8.85 | 16.18 | |
| Current Ratio | 9.35 | 12.38 | 9.84 | 9.78 | 8.96 | 16.46 | |
| Return on Equity (ROE) | -54.15% | -55.51% | -43.00% | -18.24% | -37.03% | -27.71% | |
| Return on Assets (ROA) | -25.82% | -26.84% | -22.55% | -9.94% | -16.59% | -16.93% | |
| Return on Capital (ROIC) | -27.19% | -28.58% | -23.86% | -10.61% | -17.78% | -17.79% | |
| Earnings Yield | -66.92% | -60.59% | -37.53% | -8.56% | -8.94% | -5.83% | |
| FCF Yield | -51.45% | -44.29% | -24.88% | -9.70% | -5.11% | -5.94% | |
| Buyback Yield / Dilution | -22.14% | -9.63% | -5.39% | -12.84% | -19.11% | -249.11% | |
| Total Shareholder Return | -22.14% | -9.63% | -5.39% | -12.84% | -19.11% | -249.11% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.